$PAA
PLAINS ALL AMERICAN PIPELINE LP

2023 Q2 Form 10-Q Financial Statement

#000107042323000012 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $11.60B $12.34B $13.69B
YoY Change -29.08% -9.88% 63.35%
Cost Of Revenue $10.88B $11.32B $12.79B
YoY Change -29.02% -11.44% 72.96%
Gross Profit $725.0M $1.018B $909.0M
YoY Change -29.95% 11.99% -8.27%
Gross Profit Margin 6.25% 8.25% 6.64%
Selling, General & Admin $85.00M $86.00M $82.00M
YoY Change 8.97% 4.88% 22.39%
% of Gross Profit 11.72% 8.45% 9.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $259.0M $256.0M $230.0M
YoY Change 7.02% 11.3% 29.94%
% of Gross Profit 35.72% 25.15% 25.3%
Operating Expenses $344.0M $342.0M $312.0M
YoY Change 7.5% 9.62% 27.87%
Operating Profit $381.0M $473.0M $293.0M
YoY Change -7.3% 61.43% -44.3%
Interest Expense -$6.000M $98.00M $107.0M
YoY Change -106.06% -8.41% 0.0%
% of Operating Profit -1.57% 20.72% 36.52%
Other Income/Expense, Net $20.00M $64.00M -$37.00M
YoY Change -116.95% -272.97% -38.33%
Pretax Income $392.0M $528.0M $246.0M
YoY Change 31.54% 114.63% -44.97%
Income Tax $43.00M $53.00M $21.00M
% Of Pretax Income 10.97% 10.04% 8.54%
Net Earnings $227.0M $422.0M $187.0M
YoY Change 11.82% 125.67% -55.69%
Net Earnings / Revenue 1.96% 3.42% 1.37%
Basic Earnings Per Share
Diluted Earnings Per Share $0.33 $0.52 $265.2K
COMMON SHARES
Basic Shares Outstanding 698.4M shares 698.4M shares 705.0M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $933.0M $526.0M $114.0M
YoY Change 249.44% 361.4% 280.0%
Cash & Equivalents $933.0M $526.0M $114.0M
Short-Term Investments
Other Short-Term Assets $137.0M $165.0M $320.0M
YoY Change -51.93% -48.44% -33.75%
Inventory $367.0M $463.0M $527.0M
Prepaid Expenses
Receivables $3.607B $4.141B $5.496B
Other Receivables -$387.0M -$173.0M $9.620B
Total Short-Term Assets $4.657B $5.122B $8.097B
YoY Change -30.09% -36.74% 83.02%
LONG-TERM ASSETS
Property, Plant & Equipment $16.53B $16.50B $16.17B
YoY Change 3.49% 2.07% 10.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.062B $3.070B $3.807B
YoY Change -18.84% -19.36% 0.79%
Other Assets $386.0M $430.0M $293.0M
YoY Change 45.11% 46.76% -71.39%
Total Long-Term Assets $22.24B $22.33B $22.55B
YoY Change 0.08% -0.94% 7.83%
TOTAL ASSETS
Total Short-Term Assets $4.657B $5.122B $8.097B
Total Long-Term Assets $22.24B $22.33B $22.55B
Total Assets $26.90B $27.46B $30.64B
YoY Change -6.88% -10.4% 20.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.295B $4.009B $6.867B
YoY Change -39.22% -41.62% 102.15%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $709.0M $708.0M $900.0M
YoY Change 12.54% -21.33% 669.23%
Total Short-Term Liabilities $4.652B $5.366B $8.570B
YoY Change -32.32% -37.39% 83.2%
LONG-TERM LIABILITIES
Long-Term Debt $7.288B $7.288B $7.986B
YoY Change -8.74% -8.74% -14.48%
Other Long-Term Liabilities $1.059B $1.012B $901.0M
YoY Change 6.86% 12.32% -2.91%
Total Long-Term Liabilities $8.646B $8.607B $9.218B
YoY Change -6.96% -6.63% -12.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.652B $5.366B $8.570B
Total Long-Term Liabilities $8.646B $8.607B $9.218B
Total Liabilities $13.30B $13.97B $17.79B
YoY Change -17.75% -21.45% 16.67%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.38B $10.24B $10.04B
YoY Change
Total Liabilities & Shareholders Equity $26.90B $27.46B $30.64B
YoY Change -6.88% -10.4% 20.97%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $227.0M $422.0M $187.0M
YoY Change 11.82% 125.67% -55.69%
Depreciation, Depletion And Amortization $259.0M $256.0M $230.0M
YoY Change 7.02% 11.3% 29.94%
Cash From Operating Activities $888.0M $743.0M $340.0M
YoY Change 12.12% 118.53% -57.02%
INVESTING ACTIVITIES
Capital Expenditures $159.0M $122.0M $101.0M
YoY Change -244.55% 20.79% 4.12%
Acquisitions
YoY Change
Other Investing Activities -$286.0M $280.0M -$9.000M
YoY Change -520.59% -3211.11% 200.0%
Cash From Investing Activities -$164.0M $158.0M -$81.00M
YoY Change 290.48% -295.06% -25.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.00M
YoY Change 733.33%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -325.0M -$776.0M -$597.0M
YoY Change -45.74% 29.98% -13.1%
NET CHANGE
Cash From Operating Activities 888.0M $743.0M $340.0M
Cash From Investing Activities -164.0M $158.0M -$81.00M
Cash From Financing Activities -325.0M -$776.0M -$597.0M
Net Change In Cash 399.0M $125.0M -$335.0M
YoY Change 164.24% -137.31% 8275.0%
FREE CASH FLOW
Cash From Operating Activities $888.0M $743.0M $340.0M
Capital Expenditures $159.0M $122.0M $101.0M
Free Cash Flow $729.0M $621.0M $239.0M
YoY Change -19.18% 159.83% -65.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
PLAINS ALL AMERICAN PIPELINE LP
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001070423
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-14569
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0582150
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
333 Clay Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1600
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77002
CY2023Q1 dei City Area Code
CityAreaCode
713
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
646-4100
CY2023Q1 dei Security12b Title
Security12bTitle
Common Units
CY2023Q1 dei Trading Symbol
TradingSymbol
PAA
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
698390006 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
526000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
401000000 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
3968000000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
3907000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
463000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
729000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
165000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
318000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
5122000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5355000000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
20138000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
20020000000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
4943000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
4770000000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
15195000000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
15250000000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
3070000000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
3084000000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2073000000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2145000000 usd
CY2023Q1 paa Linefill
Linefill
962000000 usd
CY2022Q4 paa Linefill
Linefill
961000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
347000000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
349000000 usd
CY2023Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
257000000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
284000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
430000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
464000000 usd
CY2023Q1 us-gaap Assets
Assets
27456000000 usd
CY2022Q4 us-gaap Assets
Assets
27892000000 usd
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4009000000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4044000000 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
708000000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
1159000000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
649000000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
688000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5366000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5891000000 usd
CY2023Q1 us-gaap Senior Long Term Notes
SeniorLongTermNotes
7238000000 usd
CY2022Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
7237000000 usd
CY2023Q1 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
50000000 usd
CY2022Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
50000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
307000000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
308000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1012000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1081000000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8607000000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8676000000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Partners Capital
PartnersCapital
10243000000 usd
CY2022Q4 us-gaap Partners Capital
PartnersCapital
10057000000 usd
CY2023Q1 us-gaap Partners Capital Attributable To Noncontrolling Interest
PartnersCapitalAttributableToNoncontrollingInterest
3240000000 usd
CY2022Q4 us-gaap Partners Capital Attributable To Noncontrolling Interest
PartnersCapitalAttributableToNoncontrollingInterest
3268000000 usd
CY2023Q1 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
13483000000 usd
CY2022Q4 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
13325000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27456000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27892000000 usd
CY2023Q1 us-gaap Revenues
Revenues
12341000000 usd
CY2022Q1 us-gaap Revenues
Revenues
13694000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11323000000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12785000000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
357000000 usd
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
346000000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
86000000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
82000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
256000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
230000000 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
154000000 usd
CY2022Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
42000000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
11868000000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
13401000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
473000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
293000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
89000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
97000000 usd
CY2023Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2000000 usd
CY2022Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
98000000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
107000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64000000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-37000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
528000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
246000000 usd
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
61000000 usd
CY2022Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
19000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8000000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
475000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
225000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
53000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
38000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
422000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
187000000 usd
CY2023Q1 paa Net Income Loss Allocated To Common Unitholders Basic
NetIncomeLossAllocatedToCommonUnitholdersBasic
361000000 usd
CY2023Q1 paa Net Income Loss Allocated To Common Unitholders Diluted
NetIncomeLossAllocatedToCommonUnitholdersDiluted
361000000 usd
CY2022Q1 paa Net Income Loss Allocated To Common Unitholders Basic
NetIncomeLossAllocatedToCommonUnitholdersBasic
137000000 usd
CY2022Q1 paa Net Income Loss Allocated To Common Unitholders Diluted
NetIncomeLossAllocatedToCommonUnitholdersDiluted
137000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
475000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
225000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
74000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
474000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
299000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
53000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
38000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
421000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
261000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
475000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
225000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
256000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
230000000 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
154000000 usd
CY2022Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
42000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8000000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2000000 usd
CY2023Q1 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
58000000 usd
CY2022Q1 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-44000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
89000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
97000000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
108000000 usd
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
96000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-15000000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4000000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-198000000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
122000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
743000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
340000000 usd
CY2023Q1 paa Capital Contributions To Equity Method Investees
CapitalContributionsToEquityMethodInvestees
4000000 usd
CY2022Q1 paa Capital Contributions To Equity Method Investees
CapitalContributionsToEquityMethodInvestees
3000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
122000000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
101000000 usd
CY2022Q1 paa Cash Paid Related To Purchases Of Linefill
CashPaidRelatedToPurchasesOfLinefill
39000000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
284000000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
53000000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-9000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
158000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-81000000 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
382000000 usd
CY2023Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
400000000 usd
CY2022Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
750000000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25000000 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
78000000 usd
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
59000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-56000000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
19000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-776000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-597000000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
125000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-335000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
401000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
453000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
526000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
65000000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
74000000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-18000000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
23000000 usd
CY2022Q4 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
13325000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
475000000 usd
CY2023Q1 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
325000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000 usd
CY2023Q1 us-gaap Partners Capital Other
PartnersCapitalOther
9000000 usd
CY2023Q1 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
13483000000 usd
CY2021Q4 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
12810000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
225000000 usd
CY2022Q1 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
235000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
74000000 usd
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
25000000 usd
CY2022Q1 us-gaap Partners Capital Other
PartnersCapitalOther
5000000 usd
CY2022Q1 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
12854000000 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023Q1 us-gaap Revenues
Revenues
12341000000 usd
CY2022Q1 us-gaap Revenues
Revenues
13694000000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
229000000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
31000000 usd
CY2023Q1 paa Contractwith Customer Liability Additions
ContractwithCustomerLiabilityAdditions
6000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
204000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
448000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
542000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
487000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
230000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
183000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
973000000 usd
CY2022 paa Trade Accounts Receivable Net Disclosure Of Maximum Age Of Balances Past Invoice Date
TradeAccountsReceivableNetDisclosureOfMaximumAgeOfBalancesPastInvoiceDate
P30D
CY2023Q1 paa Trade Accounts Receivable Net Disclosure Of Maximum Age Of Balances Past Invoice Date
TradeAccountsReceivableNetDisclosureOfMaximumAgeOfBalancesPastInvoiceDate
P30D
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4141000000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4141000000 usd
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
6912000000 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
7216000000 usd
CY2023Q1 paa Contract With Customer Contractual Rights Of Offset With Counterparties
ContractWithCustomerContractualRightsOfOffsetWithCounterparties
7085000000 usd
CY2022Q4 paa Contract With Customer Contractual Rights Of Offset With Counterparties
ContractWithCustomerContractualRightsOfOffsetWithCounterparties
7450000000 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
3968000000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
3907000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
422000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
187000000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
2000000 usd
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
1000000 usd
CY2023Q1 paa Other Adjustments Impacting Earnings Basic
OtherAdjustmentsImpactingEarningsBasic
-1000000 usd
CY2023Q1 paa Net Income Loss Allocated To Common Unitholders Basic
NetIncomeLossAllocatedToCommonUnitholdersBasic
361000000 usd
CY2023Q1 paa Net Income Loss Allocated To Common Unitholders Diluted
NetIncomeLossAllocatedToCommonUnitholdersDiluted
361000000 usd
CY2022Q1 paa Net Income Loss Allocated To Common Unitholders Diluted
NetIncomeLossAllocatedToCommonUnitholdersDiluted
137000000 usd
CY2022Q1 paa Net Income Loss Allocated To Common Unitholders Basic
NetIncomeLossAllocatedToCommonUnitholdersBasic
137000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
463000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
729000000 usd
CY2023Q1 paa Linefill
Linefill
962000000 usd
CY2022Q4 paa Linefill
Linefill
961000000 usd
CY2023Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
257000000 usd
CY2022Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
284000000 usd
CY2023Q1 paa Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
1682000000 usd
CY2022Q4 paa Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
1974000000 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
708000000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
1159000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7288000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7287000000 usd
CY2023Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
7996000000 usd
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
8446000000 usd
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
144000000 usd
CY2022Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
102000000 usd
CY2023Q1 paa Initial Margin
InitialMargin
74000000 usd
CY2022Q4 paa Initial Margin
InitialMargin
93000000 usd
CY2023Q1 paa Variation Margin Posted Returned
VariationMarginPostedReturned
-85000000 usd
CY2022Q4 paa Variation Margin Posted Returned
VariationMarginPostedReturned
-236000000 usd
CY2023Q1 us-gaap Derivative Asset Collateral Obligation To Return Cash Offset
DerivativeAssetCollateralObligationToReturnCashOffset
36000000 usd
CY2022Q4 us-gaap Derivative Asset Collateral Obligation To Return Cash Offset
DerivativeAssetCollateralObligationToReturnCashOffset
168000000 usd
CY2023Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
11000000 usd
CY2022Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
12000000 usd
CY2023Q1 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
99000000 usd
CY2022Q1 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
97000000 usd
CY2023Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
73000000 usd
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
45000000 usd
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
74000000 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
79000000 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q1 us-gaap Revenues
Revenues
12341000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
89000000 usd
CY2023Q1 paa Segment Adjusted Ebitda
SegmentAdjustedEBITDA
709000000 usd
CY2023Q1 paa Maintenance Capital Expenditures
MaintenanceCapitalExpenditures
48000000 usd
CY2022Q1 us-gaap Revenues
Revenues
13694000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
97000000 usd
CY2022Q1 paa Segment Adjusted Ebitda
SegmentAdjustedEBITDA
614000000 usd
CY2022Q1 paa Maintenance Capital Expenditures
MaintenanceCapitalExpenditures
27000000 usd
CY2023Q1 paa Segment Adjusted Ebitda
SegmentAdjustedEBITDA
709000000 usd
CY2022Q1 paa Segment Adjusted Ebitda
SegmentAdjustedEBITDA
614000000 usd
CY2023Q1 paa Depreciation And Amortization Of Unconsolidated Entities
DepreciationAndAmortizationOfUnconsolidatedEntities
22000000 usd
CY2022Q1 paa Depreciation And Amortization Of Unconsolidated Entities
DepreciationAndAmortizationOfUnconsolidatedEntities
20000000 usd
CY2023Q1 paa Gains Losses From Derivative Activities And Inventory Valuation Adjustments
GainsLossesFromDerivativeActivitiesAndInventoryValuationAdjustments
-92000000 usd
CY2022Q1 paa Gains Losses From Derivative Activities And Inventory Valuation Adjustments
GainsLossesFromDerivativeActivitiesAndInventoryValuationAdjustments
-88000000 usd
CY2023Q1 paa Long Term Inventory Costing Adjustments
LongTermInventoryCostingAdjustments
29000000 usd
CY2022Q1 paa Long Term Inventory Costing Adjustments
LongTermInventoryCostingAdjustments
-92000000 usd
CY2023Q1 paa Deficiencies Under Minimum Volume Commitments Net
DeficienciesUnderMinimumVolumeCommitmentsNet
-7000000 usd
CY2022Q1 paa Deficiencies Under Minimum Volume Commitments Net
DeficienciesUnderMinimumVolumeCommitmentsNet
6000000 usd
CY2023Q1 paa Equity Indexed Compensation Expense Awards That Will Be Settled In Units
EquityIndexedCompensationExpenseAwardsThatWillBeSettledInUnits
10000000 usd
CY2022Q1 paa Equity Indexed Compensation Expense Awards That Will Be Settled In Units
EquityIndexedCompensationExpenseAwardsThatWillBeSettledInUnits
7000000 usd
CY2023Q1 paa Net Gain Loss On Foreign Currency Revaluation
NetGainLossOnForeignCurrencyRevaluation
3000000 usd
CY2022Q1 paa Net Gain Loss On Foreign Currency Revaluation
NetGainLossOnForeignCurrencyRevaluation
2000000 usd
CY2023Q1 paa Adjusted Ebitda Attributable To Noncontrolling Interests
AdjustedEBITDAAttributableToNoncontrollingInterests
98000000 usd
CY2022Q1 paa Adjusted Ebitda Attributable To Noncontrolling Interests
AdjustedEBITDAAttributableToNoncontrollingInterests
76000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
256000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
230000000 usd
CY2023Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
154000000 usd
CY2022Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
42000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
98000000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
107000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64000000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-37000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
528000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
246000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
475000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
225000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
53000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
38000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
422000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
187000000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001070423-23-000012-index-headers.html Edgar Link pending
0001070423-23-000012-index.html Edgar Link pending
0001070423-23-000012.txt Edgar Link pending
0001070423-23-000012-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
paa-20230331.htm Edgar Link pending
paa-20230331.xsd Edgar Link pending
paaq12023exhibit311.htm Edgar Link pending
paaq12023exhibit312.htm Edgar Link pending
paaq12023exhibit321.htm Edgar Link pending
paaq12023exhibit322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
paa-20230331_def.xml Edgar Link unprocessable
paa-20230331_cal.xml Edgar Link unprocessable
paa-20230331_lab.xml Edgar Link unprocessable
paa-20230331_pre.xml Edgar Link unprocessable
paa-20230331_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending